Moreover, the abundance of miR-155 in the FF in PCOS is negatively correlated with HMGB1 concentration (97)
Discontinuation rate: 18.2% at 12mg due to adverse events
As the metabolic health movement gains further traction in 2025, GLP-1 pathways are increasingly being viewed as a cornerstone of strategic, sustainable weight support
In a statement to the Guardian, a spokesperson for Hims & Hers said that their senior medical advisers see meaningful potential in several peptide therapies, and we welcome the FDAs move to evaluate regulated access to certain peptides for compounding, adding that they manufacture all peptides in-house, ensuring direct control over safety and quality control
What increased the confusion was the commercial availability of antibodies that cross-react and detect both mice and rat immunoglobulins, while there is also both polyclonal rat-anti-mouse and mouse-anti-rat antibodies as matched pairs for rat and mouse-based sandwich ELISA without any hint or instructions about the extent of cross-reaction among both
It is also good to hear about the safety profile of these new oral GLP-1RA drugs especially the liver results and it will be good to see the data in a full publication in due course, Professor Naveed Sattar, Professor of Cardiometabolic Medicine/Honorary Consultant, University of Glasgow shared